Benefits of the bisphosphonates may extend beyond fracture prevention to include reductions in cardiovascular and cancer events and possibly mortality, according to a New Zealand trial. A more in-depth analysis of a six year trial of zoledronate in older women with osteopenia has found benefits on cardiovascular disease and some cancers consistent with those seen ...
Zoledronate benefits extend to cardiovascular & cancer events
By Michael Woodhead
31 Oct 2019